562
Participants
Start Date
March 1, 2024
Primary Completion Date
September 30, 2025
Study Completion Date
November 1, 2025
Cytoflavin
Cytoflavin solution for infusions. 20-40 ml/day (10 ml with the interval of 8-12 hours for 10 days; the single dose is increased up to 20 ml in case of the severe form of the disease) by intravenous drop infusion in dilution per 100-200 ml of 0.9% sodium chloride solution for 10 days; rate of administration: 3-4 ml/min
RECRUITING
"Ivanovo Regional Clinical Hospital", Ivanovo
RECRUITING
Kazan State Medical University, Kazan'
RECRUITING
State Autonomous Institution of Health Interregional clinical diagnostic center, Kazan'
RECRUITING
Moscow City Clinical Hospital No.64 (CCH named after V.V. Vinogradov), Moscow
RECRUITING
N.I. Pirogov City Clinical Hospital No. 1, Moscow
RECRUITING
Vorohobov's City Clinical Hospital №67, Moscow
RECRUITING
City Clinical Hospital No. 1 Novosibirsk, Novosibirsk
RECRUITING
Alexandrovskaya hospital, Saint Petersburg
RECRUITING
Almazov National Medical Research Centr, Saint Petersburg
RECRUITING
City Mariinsky Hospital, Saint Petersburg
RECRUITING
Nikolaevskaya Hospital, Saint Petersburg
RECRUITING
Saint-Petersburg I. I. Dzhanelidze research institute of emergency medicine, Saint Petersburg
RECRUITING
"St. Petersburg State Budgetary Institution of Public Health City Hospital No. 40 of Kurortny District", Saint Petersburg
RECRUITING
The City Hospital of the Holy Martyr Elizabeth, Saint Petersburg
RECRUITING
Smolensk Regional Clinical Hospital, Smolensk
RECRUITING
Municipal Clinical Hospital #13, the City of Ufa, State Budgetary Healthcare Institution of the Republic of Bashkortostan, Ufa
RECRUITING
"Budgetary healthcare institution of the Voronezh region Voronezh Regional Clinical Hospital No. 1", Voronezh
POLYSAN Scientific & Technological Pharmaceutical Company
INDUSTRY